Contoro Robotics
Series A in 2025
Contoro Robotics specializes in developing AI-powered robots for safe trailer and container unloading. Their robots autonomously pick up cases, recognize text, and palletize them, minimizing human intervention and robot downtime.
Pilleye
Seed Round in 2023
Pilleye is a mobile application that uses artificial intelligence to automatically detect and count medications, including challenging forms such as half-pills and gel capsules. This platform aims to reduce medication errors and improve workflow efficiency for healthcare providers and pharmacists.
Contoro Robotics
Seed Round in 2023
Contoro Robotics specializes in developing AI-powered robots for safe trailer and container unloading. Their robots autonomously pick up cases, recognize text, and palletize them, minimizing human intervention and robot downtime.
Actnova
Seed Round in 2022
Actnova is a Korean startup specializing in AI-driven image processing technology. The company focuses on developing a Software as a Service (SaaS) product designed for analyzing video footage from animal experiments, specifically tracking behavior. Actnova's platform automates the behavioral system testing process in animal models used in both clinical and non-clinical research fields. This enables researchers in the bio industry and academia to efficiently observe and evaluate experimental animals during stability and efficacy tests.
Pilleye
Seed Round in 2022
Pilleye is a mobile application that uses artificial intelligence to automatically detect and count medications, including challenging forms such as half-pills and gel capsules. This platform aims to reduce medication errors and improve workflow efficiency for healthcare providers and pharmacists.
Proid is a developer of precision medical imaging devices tailored for the medical field, specifically to assist medical professionals during cancer surgeries. The company's AI optical sensor solutions enable healthcare providers to accurately differentiate between cancerous and normal tissue. This capability is crucial for ensuring the complete excision of cancerous tissues, ultimately enhancing surgical outcomes. Proid's technology aids in quickly informing cryoscopic examination results, thereby improving the decision-making process during critical surgical procedures.
Lunit
Venture Round in 2021
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
BinaryVR, Inc. is a technology company based in Burlingame, California, that specializes in developing facial expression tracking technology for virtual reality and mobile applications. Established in 2015, the company focuses on enabling users to create personalized 3D representations of their faces using 2D facial photos, which allows for real-time tracking and retargeting of facial animations on various computer-generated characters or avatars. By operating at the intersection of research and development and product innovation, BinaryVR is committed to advancing the field of computer vision and enhancing interactions between artificial intelligence and everyday life. In 2020, BinaryVR became a subsidiary of Epic Games, further positioning it within the rapidly evolving technology landscape.
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
Ripple AI
Seed Round in 2018
RippleAI is a company based in Seoul, South Korea, focused on developing an artificial intelligence platform that analyzes diverse customer data from online sources, including videos, photos, voices, and emoticons. Founded in 2018, RippleAI's technology leverages emotional artificial intelligence to facilitate interactive advertising by interpreting human emotions through various forms of digital communication. This approach allows clients to gain insights into consumer sentiments and reactions, enhancing their ability to connect with audiences effectively.
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
BinaryVR
Seed Round in 2015
BinaryVR, Inc. is a technology company based in Burlingame, California, that specializes in developing facial expression tracking technology for virtual reality and mobile applications. Established in 2015, the company focuses on enabling users to create personalized 3D representations of their faces using 2D facial photos, which allows for real-time tracking and retargeting of facial animations on various computer-generated characters or avatars. By operating at the intersection of research and development and product innovation, BinaryVR is committed to advancing the field of computer vision and enhancing interactions between artificial intelligence and everyday life. In 2020, BinaryVR became a subsidiary of Epic Games, further positioning it within the rapidly evolving technology landscape.
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
Stratio
Seed Round in 2014
Stratio, Inc. is a technology company based in Palo Alto, California, that specializes in infrared sensing solutions. Founded in 2013, Stratio has developed groundbreaking products, including LinkSquare, a compact spectrometer, and BeyonSense, the first smartphone-compatible shortwave infrared camera. The company created the world's first germanium-based shortwave infrared sensor, which facilitates the development of portable and affordable infrared devices. Stratio's products are utilized globally by various partners and customers to enhance process efficiency, combat counterfeiting, ensure food safety, and support precision agriculture. The company is also focused on advancing its technology and aims to develop hyper-spectral imaging solutions in the near future.